My Pages

Stat

Members: 3645
Articles: 2'506'133
Articles rated: 2609

28 April 2024

» search

Search for articles, messages and online reviews

Results 1 to 17 of 17 for query "Acheson, D W". (0.00 sec.)

Patients with haemolytic uraemic syndrome caused by Escherichia coli O157: absence of antibodies to Vero cytotoxin 1 (VT1) or VT2.
Chart, H; Law, D; Rowe, B; Acheson, D W;

A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit.
Calderwood, S B; Acheson, D W; Goldberg, M B; Boyko, S A; Donohue-Rolfe, A;

Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems.
Acheson, D W; Calderwood, S B; Boyko, S A; Lincicome, L L; Kane, A V; Donohue-Rolfe, A; Keusch, G T;

Mitomycin immunoblot colony assay for detection of Shiga-like toxin-producing Escherichia coli in fecal samples: comparison with DNA probes.
Hull, A E; Acheson, D W; Echeverria, P; Donohue-Rolfe, A; Keusch, G T;

Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies.
Donohue-Rolfe, A; Acheson, D W; Kane, A V; Keusch, G T;

Evaluation of the premier EHEC assay for detection of Shiga toxin-producing Escherichia coli.
Kehl, K S; Havens, P; Behnke, C E; Acheson, D W;

Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells.
Jacewicz, M S; Acheson, D W; Mobassaleh, M; Donohue-Rolfe, A; Balasubramanian, K A; Keusch, G T;

Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains.
Butterton, J R; Ryan, E T; Acheson, D W; Calderwood, S B;

Translocation of Shiga toxin across polarized intestinal cells in tissue culture.
Acheson, D W; Moore, R; De Breucker, S; Lincicome, L; Jacewicz, M; Skutelsky, E; Keusch, G T;

10.

Regulation of the Shiga-like toxin II operon in Escherichia coli.
Mühldorfer, I; Hacker, J; Keusch, G T; Acheson, D W; Tschäpe, H; Kane, A V; Ritter, A; Olschläger, T; Donohue-Rolfe, A;

11.

Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR.
Acheson, D W; Levine, M M; Kaper, J B; Keusch, G T;

12.

Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e.
Keusch, G T; Jacewicz, M; Acheson, D W; Donohue-Rolfe, A; Kane, A V; McCluer, R H;

13.

Expression and purification of Shiga-like toxin II B subunits.
Acheson, D W; De Breucker, S A; Jacewicz, M; Lincicome, L L; Donohue-Rolfe, A; Kane, A V; Keusch, G T;

14.

Stability of Leapfrogging Vortex Pairs: A Semi-analytic Approach
Brandon M. Behring; Roy H. Goodman;
23 Aug 2019

15.

GT160-246, a Toxin Binding Polymer for Treatment of Clostridium difficile Colitis
Kurtz, Caroline B.; Cannon, E. Pat; Brezzani, Alex; Pitruzzello, Mary; Dinardo, Carol; Rinard, Emilie; Acheson, David W. K.; Fitzpatrick, Richard; Kelly, Pamela; Shackett, Keith; Papoulis, Andrew T.; Goddard, Philip J.; Barker, Robert H.; Palace, Gerard P.; Klinger, Jeffrey D.;
6 Jun 2005

16.

Experimental apparatus for selection of adherent microorganisms under stringent growth conditions.
Murgel, G A; Lion, L W; Acheson, C; Shuler, M L; Emerson, D; Ghiorse, W C;

17.

Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
Lin, Pengnian; Buxton, Jake A.; Acheson, Ann; Radziejewski, Czeslaw; Maisonpierre, Peter C.; Yancopoulos, George D.; Channon, Keith M.; Hale, Laura P.; Dewhirst, Mark W.; George, Samuel E.; Peters, Kevin G.;

ScienXe.org
» my Online CV
» Free

News, job offers and information for researchers and scientists:

home

contact

Search in 2'506'133 articles.